$AMLX news
The latest AMLX stock news: headlines, filings, AI summaries and sentiment for $AMLX, updated around the clock.
- Amylyx Pharmaceuticals Reports Positive Phase 3 LUCIDITY Trial Results and Q3 2026 Financials
- Amylyx Pharmaceuticals, Inc. - 10-Q Filing
- Amylyx Pharmaceuticals, Inc. - 8-K Filing
- uniQure Reports Q3 2026 Financial Results and AMT-130 Clinical Updates
- Amylyx Pharmaceuticals Scheduled to Report Q3 2026 Earnings on November 5
- Amylyx Pharmaceuticals, Inc. - 8-K Filing
- Amylyx Pharmaceuticals Shares Surge Nearly 79% on Positive Trial Results and Analyst Upgrades
- Amylyx Reports Positive Phase 3 Trial Results for GLP-1 Drug Avexitide
- Amylyx Pharmaceuticals Prices Upsized $500 Million Public Offering
- Amylyx Pharmaceuticals, Inc. - 8-K Filing
- Amylyx Pharmaceuticals Stock Rises on Pipeline Progress
- Amylyx Pharmaceuticals Advances Pipeline Programs in 2026
- Amylyx Pharmaceuticals Reports Q1 2026 Financial Results and Pipeline Updates
- Amylyx (AMLX) Q1 2026 Earnings Call Summary
- Teva Pharmaceutical Industries Reports Q1 Earnings and Announces Acquisition of Amylyx